MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 529310 | Name: Etiprednol dicloacetate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Etiprednol dicloacetate is a corticosteroid potentially for the treatment of Crohn's disease.

Chemical Structure

Etiprednol dicloacetate
Etiprednol dicloacetate
CAS#199331-40-3 (dicloacetate)

Theoretical Analysis

MedKoo Cat#: 529310

Name: Etiprednol dicloacetate

CAS#: 199331-40-3 (dicloacetate)

Chemical Formula: C24H30Cl2O6

Exact Mass: 484.1419

Molecular Weight: 485.40

Elemental Analysis: C, 59.39; H, 6.23; Cl, 14.61; O, 19.78

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
182069-13-2 (free base) 199331-40-3 (dicloacetate)
Synonym
BNP-166; BNP166; BNP 166
IUPAC/Chemical Name
ethyl (8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dichloroacetoxy)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate
InChi Key
QAIOVDNCIZSSSF-RFAJLIJZSA-N
InChi Code
InChI=1S/C24H30Cl2O6/c1-4-31-21(30)24(32-20(29)19(25)26)10-8-16-15-6-5-13-11-14(27)7-9-22(13,2)18(15)17(28)12-23(16,24)3/h7,9,11,15-19,28H,4-6,8,10,12H2,1-3H3/t15-,16-,17-,18+,22-,23-,24-/m0/s1
SMILES Code
C[C@@]12[C@](C(OCC)=O)(OC(C(Cl)Cl)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 485.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kurucz I, Tóth S, Németh K, Török K, Csillik-Perczel V, Pataki A, Salamon C, Nagy Z, Székely JI, Horváth K, Bodor N. Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166). J Pharmacol Exp Ther. 2003 Oct;307(1):83-92. PubMed PMID: 12893841. 2: Kurucz I, Németh K, Mészáros S, Török K, Nagy Z, Zubovics Z, Horváth K, Bodor N. Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid. Pharmazie. 2004 May;59(5):412-6. PubMed PMID: 15212312. 3: Patthy M, Seres G, Csanádi A, Szekeres T, Zubovics Z, Bodor N. HPLC separation of related impurities in etiprednol dicloacetate, a novel soft corticosteroid. Pharmazie. 2004 May;59(5):382-6. PubMed PMID: 15212306. 4: Csanádi A, Horváth G, Szekeres T, Haskó T, Ila L, Ivanics J, Patthy M, Salát J, Seres G, Pallagi I, Tóth G, Szederkényi F, Kónya A, Tegdes A, Bodor N, Zubovics Z. Etiprednol dicloacetate, a new soft glucocorticoid drug candidate. Development of chemistry. Pharmazie. 2004 May;59(5):349-59. PubMed PMID: 15212300. 5: Samir A, Bodor N, Imai T. Identification of esterase involved in the metabolism of two corticosteroid soft drugs. Biochem Pharmacol. 2017 Mar 1;127:82-89. doi: 10.1016/j.bcp.2016.12.010. PubMed PMID: 28017774. 6: Bodor N, Buchwald P. Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids. Curr Pharm Des. 2006;12(25):3241-60. Review. PubMed PMID: 17020532. 7: Bodor N, Buchwald P. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS J. 2005 Dec 7;7(4):E820-33. Review. PubMed PMID: 16594634; PubMed Central PMCID: PMC2750951. 8: Miklós A, Magyar Z, Kiss E, Novák I, Grósz M, Nyitray M, Dereszlay I, Czégeni E, Druga A, Howes J, Bodor N. 28-day oral toxicity study with soft corticosteroid BNP-166 in rats and dogs, followed by a 14-day recovery period. Pharmazie. 2002 Feb;57(2):142-6. PubMed PMID: 11878192. 9: Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2003 May;25(4):317-40. PubMed PMID: 12808477.